Evidence map›Paper›PMID 32989286›Full record

ArticleNature biomedical engineering2021

AND-gate contrast agents for enhanced fluorescence-guided surgery.

John C Widen, Martina Tholen, Joshua J Yim, Alexander Antaris, Kerriann M Casey, Stephan Rogalla, Alwin Klaassen, Jonathan Sorger, Matthew Bogyo

Open access · greenAbstract read
In one paragraph

Article in Nature biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 135 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

John C WidenDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-8973-1509
Martina TholenDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Joshua J YimDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Alexander AntarisIntuitive Surgical Inc., Sunnyvale, CA, USA.
Kerriann M CaseyDepartment of Comparative Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-4228-928X
Stephan RogallaDepartment of Medicine and Gastroenterology, Stanford University School of Medicine, Stanford, CA, USA.
Alwin KlaassenIntuitive Surgical Inc., Sunnyvale, CA, USA.
Jonathan SorgerIntuitive Surgical Inc., Sunnyvale, CA, USA.
Matthew BogyoDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA. mbogyo@stanford.edu.ORCID http://orcid.org/0000-0003-3753-4412
Stanford University · USIntuitive Surgical (United States) · USStanford Medicine · US

Funding

Dual orthogonal fluorescent protease sensors for image guided surgeryR01EB028628 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2019 to 2023
$1.9M
Generation of highly selective activity based probes using chemically modified phageR01EB026285 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2018 to 2021
$1.9M
NIBIB NIH HHS R01 EB026285NIBIB NIH HHS R01 EB028628
6 · The paper itself

Abstract

Surgical resection of tumours requires precisely locating and defining the margins between lesions and normal tissue. However, this is made difficult by irregular margin borders. Although molecularly targeted optical contrast agents can be used to define tumour margins during surgery in real time, the selectivity of the contrast agents is often limited by the target being expressed in both healthy and tumour tissues. Here, we show that AND-gate optical imaging probes that require the processing of two substrates by multiple tumour-specific enzymes produce a fluorescent signal with significantly improved specificity and sensitivity to tumour tissue. We evaluated the performance of the probes in mouse models of mammary tumours and of metastatic lung cancer, as well as during fluorescence-guided robotic surgery. Imaging probes that rely on multivariate activation to selectively target complex patterns of enzymatic activity should be useful in disease detection, treatment and monitoring.

Indexed as

AnimalsCell LineContrast MediaDisease Models, AnimalFemaleFluorescenceFluorescent DyesLung NeoplasmsMaleMammary Neoplasms, AnimalMiceMice, Inbred BALB COptical ImagingRAW 264.7 CellsSurgery, Computer-AssistedContrast MediaFluorescent Dyes

Identifiers

PMID32989286
PMCPMC7969380
OpenAlexW3089876537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.